On September 7, 2018, WHO published its new position on the dengue vaccine, Dengvaxia®. The WHO guidance was updated to account for new long-term clinical data on the vaccine that led Sanofi Pasteur to recommend a label update for their vaccine at the end of last year.

Dengue continues to pose a public health threat to people living in countries where the disease is present–as evidenced by recent news reports of dengue outbreaks on the island of La Reunion and in India. Still, the question remains: Can the only approved vaccine against dengue be used effectively in the global fight against this disease?

In order to shed some light on this topic and give an expert overview of the WHO position on Dengvaxia® along with the data and processes on which it is based, the Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) hosted a media briefing webinar on the September 28, 2018 at 8am EDT.

Watch the full recording of the webinar

"> On September 7, 2018, WHO published its new position on the dengue vaccine, Dengvaxia®. The WHO guidance was updated to account for new long-term clinical data on the vaccine that led Sanofi Pasteur to recommend a label update for their vaccine at the end of last year.

Dengue continues to pose a public health threat to people living in countries where the disease is present–as evidenced by recent news reports of dengue outbreaks on the island of La Reunion and in India. Still, the question remains: Can the only approved vaccine against dengue be used effectively in the global fight against this disease?

In order to shed some light on this topic and give an expert overview of the WHO position on Dengvaxia® along with the data and processes on which it is based, the Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) hosted a media briefing webinar on the September 28, 2018 at 8am EDT.

Watch the full recording of the webinar

" /> Webinar hosted by GDAC – Dengue vaccination: where do we go from here? - Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC)

  • event

    Webinar hosted by GDAC – Dengue vaccination: where do we go from here?

Back

September 28, 2018

On September 7, 2018, WHO published its new position on the dengue vaccine, Dengvaxia®. The WHO guidance was updated to account for new long-term clinical data on the vaccine that led Sanofi Pasteur to recommend a label update for their vaccine at the end of last year.

Dengue continues to pose a public health threat to people living in countries where the disease is present–as evidenced by recent news reports of dengue outbreaks on the island of La Reunion and in India. Still, the question remains: Can the only approved vaccine against dengue be used effectively in the global fight against this disease?

In order to shed some light on this topic and give an expert overview of the WHO position on Dengvaxia® along with the data and processes on which it is based, the Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) hosted a media briefing webinar on the September 28, 2018 at 8am EDT.

Watch the full recording of the webinar

Back to the list